Latest Investment Aims to Scale Availability of High-Quality Reproductive Health
Care and Address Infertility
Washington, D.C. – Morgan Health, the JPMorgan Chase & Co. (NYSE: JPM) business unit
focused on improving the quality, equity and affordability of employer-sponsored health care,
announced a $25 million investment in Kindbody, a leading fertility clinic network and global
family-building benefits provider for employers offering the full-spectrum of reproductive care
from preconception to postpartum through menopause. Dr. Cheryl Pegus, a Managing Director
with Morgan Health Ventures, will join Kindbody’s Board of Directors.
Kindbody’s model is unique in that it is the only family-building benefits provider for employers that
owns and operates fertility clinics. The company saves employers 25%-30% by contracting directly
to provide comprehensive virtual and in-person care to their employees. As the direct provider of
care, Kindbody is uniquely positioned to decrease cost, improve the patient experience and deliver
better health outcomes.
A new report from the World Health Organization estimated one in six people globally are
affected by infertility. “Access to high-quality fertility care is essential for health and wellbeing,
and Kindbody’s model supports patients at one of the most important moments in their lives,”
Dan Mendelson, CEO of Morgan Health, said. “By aligning and managing patients’ health needs
through its clinics and virtual support, Kindbody is leading a paradigm shift in fertility care for
millions of Americans with employer-sponsored health care.”
Founded in late 2018, Kindbody is the fertility benefits provider for 112 large employers,
covering more than 2.4 million lives. The company’s clients span virtually every industry and
include Walmart, Medtronic, Lyft and GEICO. Kindbody serves patients at 32 signature clinics
and hundreds of partner clinics in the U.S. Kindbody’s clinically-managed program covers the
full-spectrum of reproductive health, including both female and male fertility, which
encompasses fertility assessments and education, fertility preservation, genetic testing, in
vitro fertilization (IVF), donor and surrogacy services, and adoption, as well as a full
continuum of reproductive care including physical, mental and emotional support.
“The barriers associated with fertility make starting or growing a family difficult for millions of
Americans. Kindbody’s mission to provide a new fertility experience with their own health care
professionals and benefits navigation is unique. Their focus on improving access and health
outcomes helps mitigate many of the longstanding equity challenges employers and
employees,” said Dr. Pegus. “I look forward joining the Kindbody Board and working with the
leadership team to meet the health needs for the communities Kindbody serves.”
“Only three things matter in healthcare: cost, experience, and outcomes, and only Kindbody,
as the provider of care, can effectuate change in all three,” said Gina Bartasi, Founder and
Chairwoman of Kindbody. “Our partnership with Morgan Health will fuel Kindbody’s continued
growth allowing us to expand into geographies where the need for high-quality fertility care is
in the greatest demand, so that more people can access the essential care they need to
become parents. I’ve followed JPMorgan Chase and the Morgan Health team since inception,
and I’m honored to have them on our cap table and Cheryl’s expertise in the Boardroom.”
Morgan Health’s investment in Kindbody follows its recent investments in Vera Whole Health,
and subsequent investment in Castlight Health, Embold Health, Centivo, LetsGetChecked, and
research collaboration with Kaiser Permanente. Morgan Health will continue to invest in and
help scale companies focused on driving greater accountability in the U.S. health system with
the goal of expanding these offerings to the more than 150 million Americans with employer-
sponsored health care.
About Morgan Health
Morgan Health is a JPMorgan Chase business unit focused on improving employer-sponsored
health care. Through its investments and the advancement of accountable care, Morgan Health
is working to improve the quality, equity and affordability of employer-sponsored health care for
JPMorgan Chase employees, their families and the U.S. health system. The business is led by
Dan Mendelson, CEO of Morgan Health, reporting to Peter Scher, Vice Chairman of JPMorgan
Chase & Co. and a member of the firm’s Operating Committee. Morgan Health is headquartered
in Washington, D.C. Visit www.morganhealth.com.
About Kindbody
Kindbody is a technology-driven fertility clinic network and family-building benefits provider for
employers offering virtual and in-person care. Kindbody is the trusted fertility benefits provider
for 112 leading employers, covering more than 2.4 million lives. Many thousands more receive
their fertility care directly from Kindbody throughout the country at signature clinics, mobile
clinics, and partner clinics. As the fertility benefits provider, technology platform, and direct
provider of high-quality care, Kindbody delivers a seamless, integrated experience with superior
health outcomes at lower cost, making fertility care more affordable and accessible for all.
Kindbody has raised $315 million in funding from leading investors including Perceptive
Advisors, Morgan Health, GV (formerly Google Ventures), RRE Ventures, Claritas Health
Ventures, Rock Springs Capital, NFP Ventures, Whatif Ventures and TQ Ventures. For more
information, visit kindbody.com and follow us on Linkedin, Twitter, and Instagram.
